AffyImmune Therapeutics, Inc., a clinical stage biotechnology company finding safe, effective ways to use CAR T cells against solid cancers, announced that co-founder and CEO Dr. Moonsoo Jin was awarded a Research Project Grant.
May 25, 2021
· 1 min read